The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…
Malaria is caused by intra erythrocytic parasites from the genus Plasmodium. In the natural world, Plasmodium is transmitted to humans via the bite of an infected female Anopheles mosquito. Autochthonous cases occur sporadically in Europe and the United States, yet malaria in Western countries usually occurs after travel/residence in an endemic region. Asymptomatic blood donors are a source of Plasmodium infected erythrocytes- leading to transfusion-transmitted malaria (TTM)- usually from whole blood, and red blood cell concentrates (RBC). TTM is rare yet lead to more severe disease/death than natural infection if not timely managed. Global climate change and shifting malaria epidemiology challenges blood operators and transfusion medicine practitioners. In non-endemic regions, TTM can be overlooked by clinicians and laboratorians. Blood donor screening questions focussed on malaria disease have poor sensitivity/specificity. Serologic donor testing has strengths and weaknesses and only modest uptake worldwide. Most industrialized countries lack regulator-approved Plasmodium nucleic acid screening tests (NAT). Questions exist on whether NATs can detect the lowest infectious dose of Plasmodium in blood products. Clinicians may lack strategies on managing healthy donors with Plasmodium positive test results from a blood operator. The session will provide unique perspectives from a blood operator working in a region with re-emergent endemic malaria and a transfusion medicine specialist investigating a pediatric TTM in a non-emergent region. Attendees will be engaged using polling questions and a Q&A period. Response to polling questions and general comments will be documented used in other knowledge translation activities. Attendees will develop insights on how to plan for changing malaria epidemiology, evaluate malaria transfusion-transmission risk mitigation options, and educate the broader medical/scientific community on transfusion-transmitted malaria.
Learning Objectives
Identify factors involved in changing malaria epidemiology
Contrast current malaria risk deferral recommendations in the US and selected countries and how they are implemented in donor centers
Propose approaches focused on educating the larger medical community on TTM
Summarize information on the first donor screening malaria test licensed by the US Food and Drug Administration.
Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring) Evaluation
Testing and pathogen reduction technologies have improved substantially since implementation of donor deferral policies in the 1980s relating to gay, bisexual, and other men who had sex with men (gbMSM)…
This educational session presents a comprehensive exploration of post-pandemic blood utilization trends and supply challenges in North America, featuring experts from prominent blood suppliers with a national footprint—the American Red Cross, Canadian Blood Services, and Vitalant…
The biennially conducted National Blood Collection and Utilization Survey (NBCUS) provides the most comprehensive estimation of blood collection and utilization in the United States…